Skip to main content

Primary care

10-03-2023 | Primary care | News

COORDINATEd intervention boosts optimal prescribing in type 2 diabetes with ASCVD

A multifaceted, clinic-level intervention results in a marked increase in the proportion of people with type 2 diabetes and atherosclerotic cardiovascular disease receiving appropriate medications, shows the COORDINATE randomized trial.

09-12-2022 | Primary care | News

Diabetes remission code may hamper care quality

Formal recognition of type 2 diabetes remission in primary care may lead to suboptimal health monitoring, a study suggests.

13-09-2022 | Risk factors | News

Subjective energy levels predict cardiovascular events in type 2 diabetes

Researchers find that a single questionnaire item assessing vitality predicts major adverse cardiovascular events in people with type 2 diabetes.

15-08-2022 | Comorbidities | News

Clinical complexity increasing in diabetes

Clinical complexity and treatment burden have both increased over recent years among people with diabetes in the USA, say researchers.

01-04-2022 | DUKPC 2022 | Conference coverage | News

CVD-focused SGLT2 inhibitor prescribing failing to take hold

The proven cardiovascular benefits of SGLT2 inhibitors has not led doctors to prioritize their use in people at high risk, show findings from UK general practice.

30-03-2022 | Healthcare systems | News

Continuity of care linked to reduced CVD risk among people with diabetes

Increased team-based continuity of care correlates with decreased risk for cardiovascular disease in people with type 2 diabetes, researchers report in Diabetes Care.

04-02-2022 | Non-alcoholic fatty liver disease | News

Doctors call for NAFLD care pathway in type 2 diabetes

Physicians feel that nonalcoholic fatty liver disease is sidelined in type 2 diabetes management and should be formally incorporated into routine primary care pathways, say Australian researchers.

25-01-2022 | Type 2 diabetes | News

Shift toward specialist care for type 2 diabetes

UK researchers find people with type 2 diabetes are increasingly being cared for in specialist settings, rather than by family doctors.